Solis Mammography

Solis Mammography

Solis Mammography operates from its Addison, Texas headquarters, having spent three decades building a network of breast-dedicated imaging centers. The firm is led by Chief Executive Officer Lisa Ashby, Chief Medical Officer Dr. Emily Sedgwick, and Chief People and Culture Officer Mary Simmons. The business concentrated on a single service line — mammography and breast diagnostics — long before single-specialty consolidation became a standard private-equity play in healthcare services. The platform deploys capital into acquiring outpatient imaging centers and scaling their operations through proprietary technology. Its portfolio spans screening and diagnostic mammograms, supported by proprietary SmartCurve hardware designed to reduce patient discomfort during compression. The firm pairs this with 3D mammography as its foundation of care and integrates artificial intelligence into image review to increase early invasive-cancer detection. Geographic density is central to the model — the acquisition of Carolina Breast Imaging and expansions into Rowlett, Rosenberg, and North Richland Hills, Texas, demonstrate a contiguous Sunbelt footprint. External partnerships with hospital systems, including MountainStar Healthcare in Utah, extend the platform through co-branded or managed-service arrangements. The firm has executed multiple acquisitions to densify its regional presence, including the purchases of Progressive Radiology and Carolina Breast Imaging. In September 2023, Solis Mammography appointed Lisa Ashby as Chief Executive Officer, consolidating executive leadership under a single operator with a mandate to accelerate center openings and partnership integrations. The company earned Great Place to Work Certification for a third consecutive year, and its clinical workforce is composed entirely of breast-specialized radiologists and technologists — a structural choice most general-radiology groups cannot match because they must spread staffing across multiple modalities. Solis Mammography’s structural edge lies in its refusal to be a generalist. It does not read orthopedic films, manage oncology suites, or bid for MRI centers. That single-modality focus creates a sourcing moat for acquisitions — the firm can approach under-managed breast-imaging units inside multi-specialty groups and offer a pure-play operational template that a diversified consolidator cannot replicate. The business model compresses the traditional radiology group structure into a repeatable, consumer-branded experience, which is unusual in a field still dominated by hospital outpatient departments.